Millennium Management
IDYA icon

Millennium Management’s IDEAYA Biosciences IDYA Stock Holding History

Millennium Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.22M Buy
+126,800
New +$4.25M ﹤0.01% 3144
2021
Q2 		– Sell
-18,200
Closed -$428K – 6755
2021
Q1 		$428K Buy
+18,200
New +$351K ﹤0.01% 4945

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management's IDYA Position: Q1 2026 in Review

Millennium Management increased its IDEAYA Biosciences (IDYA) stake by 9.8% in Q1 2026, buying an estimated $685K and bringing the position to 228,980 shares worth $7.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2458.

Millennium Management first reported a position in IDYA in Q2 2019 and has held it in 24 quarters since. The position peaked at $10.8M in Q3 2024. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Millennium Management held 228,980 shares of IDEAYA Biosciences worth $7.63M as of Q1 2026.
  • Millennium Management bought 20,432 IDEAYA Biosciences shares in Q1 2026, an estimated $685K.
  • IDEAYA Biosciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2458 holding.
  • Millennium Management first reported a position in IDEAYA Biosciences in Q2 2019 and has held it in 24 quarters since.
  • Millennium Management's IDEAYA Biosciences position peaked at $10.8M in Q3 2024.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.